CoChat
Cited by 170

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Cancer in Iran 2008 to 2025: Recent incidence trends and short‐term predictions of the future burden

Open access
Roshandel, Gholamreza, Ferlay, Jacques, Ghanbari‐Motlagh, Ali, Partovipour, Elham, Salavati, Fereshteh, Aryan, Kimia, Mohammadi, Gohar, Khoshaabi, Mostafa, Sadjadi, Alireza, Davanlou, Masoud, Asgari, Fereshteh, Abadi, Hakimeh, Aghaei, Abbas, Ahmadi‐Tabatabaei, Seyed‐Vahid, Alizadeh‐Barzian, Kazem, Asgari, Abbasali, Asgari, Noorali, Azami, Soheyla, Cheraghi, Maria, Enferadi, Floria, Eslami‐Nasab, Masoumeh, Fakhery, Jila, Farahani, Mohsen, Farrokhzad, Solmaz, Fateh, Mansooreh, Ghasemi, Ali, Ghasemi‐Kebria, Fatemeh, Gholami, Hajar, Golpazir, Arash, Hasanpour‐Heidari, Susan, Hazar, Narjes, Hoseini‐Hoshyar, Hosein, Izadi, Mohsen, Jahantigh, Mahdi, Jalilvand, Ahmad, Jazayeri, Seyed‐Mehrdad, Kazemzadeh, Yasan, Khajavi, Maryam, Khalednejad, Maryam, Khanloghi, Marziyeh, Kooshki, Maryam, Madani, Amineh, Mirheidari, Mahdi, Mohammadifar, Hosein, Moinfar, Zeinab, Mojtahedzadeh, Yasaman, Morsali, Ali, Motidost‐Komleh, Rita, Mousavi, Tahereh, Narooei, Maboobeh, Nasiri, Mohammad, Niksiar, Sharareh, Pabaghi, Mehdi, Pirnejad, Habibollah, Pournajaf, Azadeh, Pourshahi, Gita, Rahnama, Amir, Rashidpoor, Bahman, Ravankhah, Zahra, Rezaei, Khadijeh, Rezaianzadeh, Abbas, Sadeghi, Gholamreza, Salehifar, Mohammad, Shahdadi, Athareh, Shahi, Mehraban, Sharifi‐Moghaddam, Farrokh, Sherafati, Roya, Soleimani, Ali, Soltany‐hojatabad, Maryam, Somi, Mohammad‐Hossein, Yadolahi, Sohrab, Yaghoubi‐Ashrafi, Majid, Zareiyan, Aliakbar, Poustchi, Hossein, Zendehdel, Kazem, Ostovar, Afshin, Janbabaei, Ghasem, Raeisi, Alireza, Weiderpass, Elisabete, Malekzadeh, Reza, Bray, Freddie · 2021 · International Journal of Cancer

Abstract

Policymakers require estimates of the future number of cancer patients in order to allocate finite resources to cancer prevention, treatment and palliative care. We examine recent cancer incidence trends in Iran and present predicted incidence rates and new cases for the entire country for the year 2025. We developed a method for approximating population‐based incidence from the pathology‐based data series available nationally for the years 2008 to 2013, and augmented this with data from the Iranian National Population‐based Cancer Registry (INPCR) for the years 2014 to 2016. We fitted time‐linear age‐period models to the recent incidence trends to quantify the future cancer incidence burden to the year 2025, delineating the contribution of changes due to risk and those due to demographic change. The number of new cancer cases is predicted to increase in Iran from 112 000 recorded cases in 2016 to an estimated 160 000 in 2025, a 42.6% increase, of which 13.9% and 28.7% were attributed to changes in risk and population structure, respectively. In terms of specific cancers, the greatest increases in cases are predicted for thyroid (113.8%), prostate (66.7%), female breast (63.0%) and colorectal cancer (54.1%). Breast, colorectal and stomach cancers were the most common cancers in Iran in 2016 and are predicted to remain the leading cancers nationally in 2025. The increasing trends in incidence of most common cancers in Iran reinforce the need for the tailored design and implementation of effective national cancer control programs across the country.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.33574

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 170

Metadata

Authors
Roshandel, G., Ferlay, J., Ghanbari‐Motlagh, A., Partovipour, E., Salavati, F., Aryan, K., Mohammadi, G., Khoshaabi, M., Sadjadi, A., Davanlou, M., Asgari, F., Abadi, H., Aghaei, A., Ahmadi‐Tabatabaei, S., Alizadeh‐Barzian, K., Asgari, A., Asgari, N., Azami, S., Cheraghi, M., Enferadi, F., Eslami‐Nasab, M., Fakhery, J., Farahani, M., Farrokhzad, S., Fateh, M., Ghasemi, A., Ghasemi‐Kebria, F., Gholami, H., Golpazir, A., Hasanpour‐Heidari, S., Hazar, N., Hoseini‐Hoshyar, H., Izadi, M., Jahantigh, M., Jalilvand, A., Jazayeri, S., Kazemzadeh, Y., Khajavi, M., Khalednejad, M., Khanloghi, M., Kooshki, M., Madani, A., Mirheidari, M., Mohammadifar, H., Moinfar, Z., Mojtahedzadeh, Y., Morsali, A., Motidost‐Komleh, R., Mousavi, T., Narooei, M., Nasiri, M., Niksiar, S., Pabaghi, M., Pirnejad, H., Pournajaf, A., Pourshahi, G., Rahnama, A., Rashidpoor, B., Ravankhah, Z., Rezaei, K., Rezaianzadeh, A., Sadeghi, G., Salehifar, M., Shahdadi, A., Shahi, M., Sharifi‐Moghaddam, F., Sherafati, R., Soleimani, A., Soltany‐hojatabad, M., Somi, M., Yadolahi, S., Yaghoubi‐Ashrafi, M., Zareiyan, A., Poustchi, H., Zendehdel, K., Ostovar, A., Janbabaei, G., Raeisi, A., Weiderpass, E., Malekzadeh, R., & Bray, F.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2021-04-21
Volume
149
Issue
3
Pages
594-605
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W3156800397
Cited by
170
References
4
FWCI
9.95
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer in Iran 2008 to 2025: Recent incidence trends and short‐term predictions of the future burden. https://app.cochat.ai/papers/10.1002/ijc.33574
The paper
Roshandel, G., Ferlay, J., Ghanbari‐Motlagh, A., Partovipour, E., Salavati, F., Aryan, K., Mohammadi, G., Khoshaabi, M., Sadjadi, A., Davanlou, M., Asgari, F., Abadi, H., Aghaei, A., Ahmadi‐Tabatabaei, S., Alizadeh‐Barzian, K., Asgari, A., Asgari, N., Azami, S., Cheraghi, M., . . . Bray, F. (2021). Cancer in Iran 2008 to 2025: Recent incidence trends and short‐term predictions of the future burden. International Journal of Cancer. https://doi.org/10.1002/ijc.33574

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.